| 5F5Z: reference: Potent dual BET bromodomain-kinase inhibitors as value added multi-targeted chemical probes and cancer therapeutics., Ember SW, Lambert QT, Berndt N, Gunawan S, Ayaz M, Tauro M, Zhu JY, Cranfill PJ, Greninger P, Lynch CC, Benes CH, Lawrence HR, Reuther GW, Lawrence NJ, Schonbrunn E, Mol Cancer Ther. 2017 Mar 23. pii: molcanther.0568.2016. doi:, 10.1158/1535-7163.MCT-16-0568-T. PMID: 28336808 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).